International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

PreScription: New Drug Approvals 2022 and Compounding Opportunities

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2023 - Volume 27, Number 1
View All Articles in Issue

Page(s): 4

PreScription: New Drug Approvals 2022 and Compounding Opportunities Page 1

Download in electronic PDF format for $75

Abstract:

Related Keywords: 2022 new United States drug approvals, compounding potential

Related Categories: BUSINESS, MARKETING

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
PreScription: New Drug Approvals 2022 and Compounding Opportunities Allen Loyd V Jr	Jan/Feb 2023 Pg. 4
PreScription: Compounded Drugs Often Become Manufactured Drugs Allen Loyd V Jr	Nov/Dec 2022 Pg. 444
Inventory Information Approval System Certification and Flexible Spending Account Purchases: A New Year Brings Changes Shuey Brandon, Williams LaVonn A	Mar/Apr 2010 Pg. 124-128
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer Kramer Mark A, Grilley Bambi J	Jul/Aug 2002 Pg. 271-273
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Allen Loyd V Jr	Mar/Apr 2020 Pg. 92
New England Compounding Center Indictment Cabaleiro Joe	Mar/Apr 2015 Pg. 94-102
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake	Sep/Oct 2015 Pg. 377-380
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2 Allen Loyd V Jr	May/Jun 2020 Pg. 180
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Stephenson Kenna, Jones William, Stephenson Douglas M M	May/Jun 2006 Pg. 175-183
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun	Mar/Apr 2018 Pg. 108-121
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Lopez C Vidal, Rios GL Quito	Sep/Oct 2022 Pg. 358-362
PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle Allen Loyd V Jr	Jul/Aug 2010 Pg. 268
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Vail Jane	Jan/Feb 2003 Pg. 21-23
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice Kelley Brian	Mar/Apr 2021 Pg. 115-124
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Allen Loyd V Jr	Jul/Aug 2007 Pg. 350-351
Disposing of Expired Drugs and Chemicals: New Options for Compounders Vail Jane	Jan/Feb 2008 Pg. 38-47 View Sample
Return to Top